Perth Royal Infirmary is a district hospital in Perth. The Royal Infirmary serves a population of around 182,000 across the City of Perth and the wider Perth and Kinross area. It is managed by NHS Tayside.

There are 267 beds in Perth Royal Infirmary.

During the past decade, Perth Royal Infirmary conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Perth Royal Infirmary" #1 sponsor was "University of Dundee" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "David Bearn" with 1 trials sponsored, "Lisette Nixon" with 1 trials sponsored and "University Hospital Inselspital, Berne" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Perth Royal Infirmary" #1 collaborator was "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator, "NHS Lothian" with 1 trials as a collaborator, "NHS Research and Development" with 1 trials as a collaborator and "NHS Tayside" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Perth Royal Infirmary" are "Allergic Rhinitis" (1 trials), "Angina Pectoris" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Heart Disease" (1 trials) and "Demineralisation" (1 trials). Many other conditions were trialed in "Perth Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Perth Royal Infirmary" are "Drug" (4 trials), "Procedure" (3 trials), "Device" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (2 trials), "3-dimensional conformal radiation therapy" (1 trials), "Azelastine , fluticasone" (1 trials), "Computer Tomography Angiography" (1 trials) and "Early treatment with Rivaroxaban (Xarelto®), Dabigatran (Pradaxa®), Apixaban (Eliquis®) or Edoxaban (Lixiana®)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Perth Royal Infirmary" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Perth Royal Infirmary". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Perth Royal Infirmary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Perth Royal Infirmary, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".